Lab-Made Heart Valves Can Grow Along With Youngest Heart Patients
Title: Lab-Made Heart Valves Can Grow Along With Youngest Heart PatientsCategory: Health NewsCreated: 3/22/2021 12:00:00 AMLast Editorial Review: 3/22/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 22, 2021 Category: Cardiology Source Type: news

Artificial Heart Valves Grow with Lambs
Two of the implanted valves lasted a full year as the animals matured into adult sheep, demonstrating that it might be possible to treat children with valve replacements that grow along with them. (Source: The Scientist)
Source: The Scientist - March 19, 2021 Category: Science Tags: News & Opinion Source Type: news

Tri-tube heart valve replacement adapts to the growing heart in lambs
(American Association for the Advancement of Science) Combining tissue engineering and regenerative medicine, scientists have fabricated a series of heart valve replacements with the ability to incorporate host cells, enabling them to regenerate and grow over time. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 17, 2021 Category: International Medicine & Public Health Source Type: news

Lab-created heart valves can grow with the recipient
(University of Minnesota) Groundbreaking discovery could potentially reduce multiple pediatric heart valve replacement surgeries. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 17, 2021 Category: Biology Source Type: news

DOACs Offered After Heart Valve Surgery Despite Absence of Data DOACs Offered After Heart Valve Surgery Despite Absence of Data
Use of direct oral anticoagulants (DOACs), contraindicated for patients with mechanical or bioprosthetic valves, has increased steadily for surgical bioprosthetic valve replacement.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 10, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Aortic calcification: An early sign of heart valve problems?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - February 19, 2021 Category: Consumer Health News Source Type: news

Heart Valve Collaboratory announces U.S. FDA participation in collaborative community
(Cardiovascular Research Foundation) The Heart Valve Collaboratory (HVC) announced today that the U.S. Food and Drug Administration (FDA)'s Center for Devices and Radiological Health (CDRH) will participate in this " collaborative community " . A medical " collaboratory " is a forum in which multidisciplinary private and public sector members work together on medical device challenges to achieve aligned outcomes, solve shared problems, and leverage collective opportunities, in the interest of improving patient care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 16, 2021 Category: International Medicine & Public Health Source Type: news

Network-based screen in iPSC-derived cells reveals therapeutic candidate for heart valve disease
Mapping the gene-regulatory networks dysregulated in human disease would allow the design of network-correcting therapies that treat the core disease mechanism. However, small molecules are traditionally screened for their effects on one to several outputs at most, biasing discovery and limiting the likelihood of true disease-modifying drug candidates. Here, we developed a machine-learning approach to identify small molecules that broadly correct gene networks dysregulated in a human induced pluripotent stem cell (iPSC) disease model of a common form of heart disease involving the aortic valve (AV). Gene network correction...
Source: ScienceNOW - February 11, 2021 Category: Science Authors: Theodoris, C. V., Zhou, P., Liu, L., Zhang, Y., Nishino, T., Huang, Y., Kostina, A., Ranade, S. S., Gifford, C. A., Uspenskiy, V., Malashicheva, A., Ding, S., Srivastava, D. Tags: Genetics, Medicine, Diseases, Online Only r-articles Source Type: news

Breakthrough design at UBCO vastly improves mechanical heart valve
(University of British Columbia Okanagan campus) New research coming out of UBC's Okanagan campus may take the current 'gold standard' for heart valves to a new level of reliability.A team of researchers at UBCO's Heart Valve Performance Lab (HVPL) has developed a way to improve overall blood flow through the valves, so the design of mechanical heart valves will more closely match the real thing. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 26, 2021 Category: International Medicine & Public Health Source Type: news

A potential therapy for one of the leading causes of heart disease
(Gladstone Institutes) After 15 years of unrelenting work, a team of scientists from Gladstone Institutes has discovered a potential drug candidate for heart valve disease that works in both human cells and animals and is ready to move toward a clinical trial. Their findings were just published in the journal Science. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 10, 2020 Category: International Medicine & Public Health Source Type: news

Huge gap in demand, supply of organs for transplant in country: AIIMS chief
AIIMS Director Dr Randeep Guleria said the AIIMS was working to "very soon" start a lung transplant programme even as it has facilities available for transplantation of heart, kidney, liver, pancreas, cornea, heart valve and bones. (Source: The Economic Times)
Source: The Economic Times - November 27, 2020 Category: Consumer Health News Source Type: news

What Does a Leaky Heart Valve Feel Like?
Title: What Does a Leaky Heart Valve Feel Like?Category: Diseases and ConditionsCreated: 11/10/2020 12:00:00 AMLast Editorial Review: 11/10/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 10, 2020 Category: Cardiology Source Type: news

New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need for data in ...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

OrbusNeich(R) Medical and P+F Products and Features(R) announce new partnership
Introducing a new portfolio of heart valve products aiming to restore health and extend life HONG KONG, Nov. 9, 2020 -- (Healthcare Sales & Marketing Network) -- OrbusNeich and P+F today announced they have entered into an agreement for the exclusive d... Devices, Interventional, Cardiology, Distribution OrbusNeich Medical, P+F, heart valve, TricValve, Bicaval Valves (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2020 Category: Pharmaceuticals Source Type: news

Scientists Have Uncovered the Likely Cause of a Serious COVID-19 Symptom: Blood Clotting
One of the more surprising symptoms of COVID-19 has been the blood clots that many patients, including younger ones, have experienced with the infection. The clots have in some cases led to dangerous blockages in the lungs, caused strokes and even death, even in people without a history of circulatory conditions. In a paper published in Science earlier this week, researchers provide a glimpse into what may be driving the clots triggered by COVID-19 infection. The group found that a specific set of antibodies known as autoantibodies—which are rogue versions of cells meant to defend the body from pathogens, but instead...
Source: TIME: Health - November 5, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news